Molecular Diagnostics Market Size to Grow US$ 48.9 Billion By 2030

The global molecular diagnostics market size was valued at US$ 12.7 billion in 2021 and is anticipated to grow US$ 48.9 billion by 2030, registering a compound annual growth rate (CAGR) of 16.16% from 2022 to 2030.

The molecular diagnostics market report covering various industry elements and growth trends helpful for predicting the market’s future.

The study provides a strong base for the molecular diagnostics market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2030.

This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2022 to 2030. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the molecular diagnostics report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the molecular diagnostics market have been studied and analysed across many developments.

Report Scope of the Molecular Diagnostics Market

Research Approach

The comprehensive report on the global molecular diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global molecular diagnostics market.

It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs  and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Key Players are  Siemens Healthineers AG (Germany), Quidel Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Illumina, Inc. (US), Becton, Dickinson and Company (US), Grifols, S.A. (Spain), PerkinElmer, Inc. (US), Abbott Laboratories (US), bioMérieux SA (France), QIAGEN N.V. (Netherlands), Myriad Genetics, Inc. (US), Agilent Technologies, Inc. (US), geneOmbio Technologies Pvt. Ltd. (India)

Market Segmentations

By Product 

• Instruments
• Reagents
• Services & Software

By Test Location

• Central laboratories
• Point of care
• Over the counter or self-test kits

By Technology 

• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• DNA Sequencing & Next- generation Sequencing (NGS)
• In Situ Hybridization (ISH)
• DNA Microarrays
• Others

By Application

• Infectious diseases
  • COVID-19
  • Hepatitis
  • HIV
  • CT/NG
  • HAI
  • HPV
  • Tuberculosis
  • Influenza
  • Other Infectious Diseases
• Oncology
  • Breast Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other
• Genetic testing
• Neurological disease
• Microbiology

By End User

• Diagnostic Laboratories
• Hospitals & Clinics
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Molecular Diagnostics Market 

5.1. COVID-19 Landscape: Molecular Diagnostics Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Molecular Diagnostics Market, By Product

8.1. Molecular Diagnostics Market, by Product, 2022-2030

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Reagents

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Services & Software

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Molecular Diagnostics Market, By Test Location

9.1. Molecular Diagnostics Market, by Test Location, 2022-2030

9.1.1. Central laboratories

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Point of care

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Over the counter or self-test kits

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Molecular Diagnostics Market, By Technology 

10.1. Molecular Diagnostics Market, by Technology, 2022-2030

10.1.1. Polymerase Chain Reaction (PCR)

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. DNA Sequencing & Next- generation Sequencing (NGS)

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. In Situ Hybridization (ISH)

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. DNA Microarrays

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Molecular Diagnostics Market, By Application

11.1. Molecular Diagnostics Market, by Application, 2022-2030

11.1.1. Infectious diseases

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Oncology

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Genetic testing

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Neurological disease

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Microbiology

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Molecular Diagnostics Market, By End User

12.1. Molecular Diagnostics Market, by End User, 2022-2030

12.1.1. Diagnostic Laboratories

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Hospitals & Clinics

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Others

12.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Molecular Diagnostics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.1.3. Market Revenue and Forecast, by Technology (2017-2030)

13.1.4. Market Revenue and Forecast, by Application (2017-2030)

13.1.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Technology (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Application (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.2.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.4. Market Revenue and Forecast, by Application (2017-2030)

13.2.5. Market Revenue and Forecast, by End User (2017-2030)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.7. Market Revenue and Forecast, by Application (2017-2030)

13.2.8. Market Revenue and Forecast, by End User (2017-2030)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.10. Market Revenue and Forecast, by Application (2017-2030)

13.2.11. Market Revenue and Forecast, by End User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Application (2017-2030)

13.2.13. Market Revenue and Forecast, by End User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Application (2017-2030)

13.2.15. Market Revenue and Forecast, by End User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.3.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.7. Market Revenue and Forecast, by End User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.9. Market Revenue and Forecast, by End User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Application (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.4.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.7. Market Revenue and Forecast, by End User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.9. Market Revenue and Forecast, by End User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Application (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.5.3. Market Revenue and Forecast, by Technology (2017-2030)

13.5.4. Market Revenue and Forecast, by Application (2017-2030)

13.5.5. Market Revenue and Forecast, by End User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Application (2017-2030)

13.5.7. Market Revenue and Forecast, by End User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Test Location (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Technology (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Application (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)

Chapter 14. Company Profiles

14.1. Siemens Healthineers AG (Germany)

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Quidel Corporation (US)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. F. Hoffmann-La Roche Ltd. (Switzerland)

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Hologic, Inc. (US)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Thermo Fisher Scientific, Inc. (US)

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Danaher Corporation (US)

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Illumina, Inc. (US)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Becton, Dickinson and Company (US)

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Grifols, S.A. (Spain)

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. PerkinElmer, Inc. (US)

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global molecular diagnostics market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for molecular diagnostics are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2257

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com